FRANKFURT, Oct 30 (Reuters) - Germany's Bayer BAYGn.DE said on Wednesday that the number of U.S. plaintiffs blaming its glyphosate-based weedkillers for their cancer mushroomed to 42,700 from 18,400 in July.
Third-quarter adjusted core earnings for the group rose 7.5%to 2.3 billion euros ($2.6 billion), helped by higher sales of crop protection chemicals, seeds and consumer healthcare products, it added.
(Reporting by Ludwig Burger Editing by Tassilo Hummel)
((firstname.lastname@example.org; +49 69 7565 1311; Reuters Messaging: email@example.com))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.